Preventive
Cancer Therapy
Product Summary
Circulating Tumor Cell (CTC) cancer therapy is a cutting-edge approach that targets and eliminates cancer cells circulating in the bloodstream. This method aims to prevent metastasis and improve patient outcomes by detecting and treating cancer at an early stage.
Positive Aspects
Our Customer Segment
The target audience includes patients with chronic pain or injuries, individuals with degenerative diseases, and athletes seeking faster recovery from sports injuries.
Cancer patients at risk of metastasis
Individuals undergoing cancer treatment
Patients seeking personalized and targeted cancer therapies
Stem cells derived from a newborn baby's umbilical cord Wharton's jelly are known for their regenerative properties and potential therapeutic applications. These are mesenchymal stem cells (MSCs) extracted from the Wharton's jelly, a gelatinous substance within the umbilical cord.
Minimally invasive treatment option
Personalized therapy tailored to the patients specific needs
Potential to enhance the effectiveness of existing cancer treatments
What Make Us
Unique
Our product stands out in the field of cancer diagnostics and treatment by offering key advantages that set it apart from traditional methods.
What You Need To Know
Frequently
Ask Questions
What is CTC testing?
Circulating Tumor Cell (CTC) testing is a non-invasive cancer screening method that detects cancer cells in the bloodstream to assess cancer risk, progression, or metastasis.
Who should consider CTC testing?
It is recommended for high-risk individuals (such as those with a family history of cancer or unhealthy lifestyle habits), post-surgery cancer patients for monitoring, and individuals seeking early cancer screening.
Can CTC testing replace traditional imaging scans?
CTC testing is a complementary screening tool and cannot completely replace CT, MRI, or other imaging scans. It is useful for early risk assessment and ongoing monitoring.
How accurate is CTC testing?
CTC testing relies on highly sensitive technology to detect even a small number of tumor cells in the blood. However, results should be interpreted by a doctor and are not a sole diagnostic tool.
Does a positive CTC test mean I have cancer?
Not necessarily. A positive CTC result may indicate the presence of cancerous activity or circulating tumor cells, but it does not confirm a cancer diagnosis. Further tests, such as imaging or biopsy, are recommended.
What is NK cell therapy?
Natural Killer (NK) cell therapy is an immunotherapy that expands high-activity NK cells outside the body and reinfuses them to enhance the immune system’s ability to eliminate cancer cells, virus-infected cells, and aging cells.
Who can benefit from NK cell therapy?
It is suitable for high-risk cancer individuals, patients undergoing cancer treatments (such as chemotherapy and radiotherapy), people with weakened immunity, and those seeking anti-aging and immune enhancement.
Are there any side effects of NK cell therapy?
NK cell therapy is generally safe with minimal side effects. Some patients may experience mild fever or temporary fatigue, which usually resolves on its own.
Can NK cell therapy be combined with other cancer treatments?
Yes. NK cell therapy can be combined with surgery, chemotherapy, radiotherapy, and targeted therapy to enhance treatment efficacy, boost immunity, and reduce the risk of recurrence.
How long does it take to see the effects of NK cell therapy?
The effects vary by individual. Some may notice improved immunity and energy levels within weeks to months, while long-term benefits may include reduced recurrence rates.
Is NK cell therapy suitable for everyone?
Most people can receive NK cell therapy, but those with severely compromised immune systems (such as late-stage cancer patients or individuals on immunosuppressive therapy) should consult a doctor to determine suitability.
Google Review